ArticleJournal of hematology & oncology2021

Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion.

Hao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.